SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today ...
Leverages HeartBeam AIMIGo™ Platform to Address the Multibillion-Dollar Global Market for Detection of Atrial Arrhythmias SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a ...
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, has been granted a patent from the ...
The company's products, HeartBeam AIMI and HeartBeam AIMIGo, are being developed with the aim of providing accurate diagnostic tools for heart attack detection anytime and anywhere. The core ...
Patented Technology Provides Protection for HeartBeam AIMIGo Credit Card-sized Device in European Market HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and ...
NEW YORK, NY / ACCESSWIRE / January 12, 2023 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently ...
3D Vector ECG Collection Device Slated for FDA 510k Submission in the Fourth Quarter of 2022 SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital ...
HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback